News Ticker

[ October 6, 2026 ] City of Hope Names New Presidents of Cancer Centers in Arizona and Atlanta Los Angeles Biotech News
[ October 6, 2026 ] MidFirst Bank Donates $35,000 to The Heart Foundation to Support Heart Disease Research and Awareness Los Angeles Biotech News
[ October 6, 2026 ] New World Medical Receives MDR Certification for Ahmed® Glaucoma Valve, Ahmed ClearPath®, and KDB GLIDE® Los Angeles Biotech News
[ October 6, 2026 ] Infleqtion, Honeywell Aerospace and UC Santa Barbara Collaborate to Accelerate Miniaturization and Manufacturability of Quantum Hardware Los Angeles Biotech News
[ October 6, 2026 ] Prostate Cancer Foundation Honors Mary-Ellen Taplin, MD, with the 2026 PCF Women in Science Lifetime Achievement Award Los Angeles Biotech News

Blackstone-backed biotech launches with up to $300M for immune drug

May 16, 2024 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off

Uniquity Bio, a startup backed by Blackstone Life Sciences, is launching with a medicine ready for Phase 2 studies and as much as $300 million from the private equity firm to spend on development.
The drug, solrikitug, originally came from Merck and has the potential to treat a…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Copyright © 2026 Biotech Networks, LLC